FDA Inspection 995153 — ImpactLife
The FDA completed an inspection of ImpactLife on December 5, 2016 in Cedar Rapids, IA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 5, 2016
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Cedar Rapids, IA (United States)